Analyst Ratings Coverage Update: July 10th, 2025

Jul 12, 2025
analyst-ratings-coverage-update:-july-10th,-2025

Analyst Ratings (USA)

American Airlines Group (AAL) had its target price raised to $12.00 by Barclays, maintaining an Equal Weight rating.

Acadian Asset Management (AAMI) had its target raised to $34.00 by Royal Bank of Canada, with a Sector Perform rating.

Arch Capital Group (ACGL) had its target raised to $110.00 by Wells Fargo & Company, keeping an Overweight rating.

Amylyx Pharmaceuticals (AMLX) was initiated with a Buy rating and a $10.00 target by Goldman Sachs.

Ameriprise Financial (AMP) had its target price increased to $595.00 by Royal Bank of Canada, maintaining an Outperform rating.

Amplitude (AMPL) was reiterated with a Buy rating and a $16.00 target by Needham & Company.

Amprius Technologies (AMPX) was reiterated with a Buy rating by B. Riley, which raised the target to $10.00.

Amazon.com (AMZN) had its target lifted to $285.00 by JMP Securities, keeping a Market Outperform rating.

Amazon.com (AMZN) also had its target raised to $300.00 by Morgan Stanley, maintaining an Overweight rating.

Amazon.com (AMZN) was reiterated with an Outperform rating and a $235.00 target by Telsey Advisory Group.

Avis Budget Group (CAR) was reiterated as a Buy by Deutsche Bank, which raised the target to $196.00.

Caterpillar (CAT) saw its target raised to $475.00 by JPMorgan Chase & Co., with an Overweight rating.

Costco Wholesale (COST) was reiterated with an Outperform rating by Telsey Advisory Group, with a $1,100.00 target.

Salesforce (CRM) had its target lowered to $335.00 by BMO Capital Markets, maintaining an Outperform rating.

Crinetics Pharmaceuticals (CRNX) was initiated at Goldman Sachs with a Neutral rating and a $36.00 target.

CrowdStrike (CRWD) was reiterated as a Hold by CFRA, which raised the price target to $555.00.

JD.com (JD) had its target cut to $28.00 by Morgan Stanley, keeping an Equal Weight rating.

Johnson & Johnson (JNJ) had its target raised to $171.00 by Morgan Stanley, keeping an Equal Weight rating.

MetLife (MET) had its target raised to $97.00 by Wells Fargo & Company, maintaining an Overweight rating.

Meta Platforms (META) saw its target increased to $765.00 by Bank of America, with a Buy rating.

Marathon Petroleum (MPC) had its target lifted to $175.00 by Piper Sandler, with a Neutral rating.

Mereo BioPharma Group (MREO) had a target of $5.00 set by Needham & Company, with a Buy rating.

Merck & Co., Inc. (MRK) had its target trimmed to $98.00 by Morgan Stanley, with an Equal Weight rating.

Marvell Technology (MRVL) was initiated by Goldman Sachs with a Neutral rating and a $75.00 target.

Microsoft (MSFT) had its target raised to $550.00 by BMO Capital Markets, maintaining an Outperform rating.

Microsoft (MSFT) also had its target lifted to $600.00 by Piper Sandler, with an Overweight rating.

Micron Technology (MU) was initiated by Deutsche Bank with a Buy rating and a $150.00 target.

Neurocrine Biosciences (NBIX) was initiated by Goldman Sachs with a Buy rating and a $182.00 target.

Nasdaq (NDAQ) had its target raised to $101.00 by Barclays, with an Overweight rating.

Nasdaq (NDAQ) also had its target raised to $95.00 by UBS Group, maintaining a Neutral rating.

NextEra Energy (NEE) had its target lifted to $67.00 by Barclays, with an Equal Weight rating.

Netflix (NFLX) had its target raised to $1,390.00 by KeyCorp, with an Overweight rating.

National Health Investors (NHI) was upgraded to Overweight by KeyCorp, with an $80.00 target.

NIKE (NKE) was downgraded to Hold by DZ Bank, with a $76.00 target.

NVIDIA (NVDA) was initiated by Goldman Sachs with a Buy rating and a $185.00 target.

NXP Semiconductors (NXPI) was initiated with a Buy rating and a $276.00 target by Goldman Sachs.

ON Semiconductor (ON) was initiated with a Neutral rating and a $60.00 target by Goldman Sachs.

Philip Morris Intl (PM) had its target raised to $190.00 by JPMorgan Chase & Co., with an Overweight rating.

Philip Morris Intl (PM) also had its target lifted to $200.00 by Citigroup, maintaining a Buy rating.

Regeneron Pharmaceuticals (REGN) had its target trimmed to $754.00 by Morgan Stanley, keeping an Overweight rating.

Roku (ROKU) had its target raised to $84.00 by Piper Sandler, with a Neutral rating.

Roku (ROKU) was upgraded to Overweight by KeyCorp, with a $115.00 target.

Workday (WDAY) was reiterated with an Underweight rating and a target of $235.00 by Piper Sandler.

XPO (XPO) had its target lifted to $145.00 by Barclays, with an Overweight rating.

Zebra Technologies (ZBRA) was upgraded to Outperform by BNP Paribas Exane, with a $408.00 target.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

Leave a comment